ArticleJournal of ovarian research2025
Investigating the potential causal link between BPA and ovarian carcinogenesis: a network toxicology and mendelian randomization study on the CTRC/PRDX1/SKP1 pathway.
Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multi-scale evidence chain: Linking environmental BPA exposure to ovarian cancer through integrated omics and experimental models.Translational oncology · 2026Article
- Bisphenol A and ovarian cancer: emerging evidence and potential biological mechanisms.Frontiers in cell and developmental biology · 2026Review
- PRDX1 promotes clear cell renal cell carcinoma progression by modulating EGFR-dependent AKT pathway activation.Frontiers in pharmacology · 2026Article
- Cancer and Environmental Xenobiotics: Mechanisms, Controversies, and Innovations.Journal of xenobiotics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study elucidates the association between Bisphenol A (BPA) exposure and ovarian cancer development, along with its underlying mechanisms. We employed a 'Toxicological Prediction-Causal Inference-Structural Validation' framework, integrating network toxicology and Mendelian Randomization (MR) analysis, enabling insights into BPA's carcinogenic effects. This approach used network toxicology to predict molecular targets of BPA in the ovary, MR to establish genetic evidence for the causal link, and molecular docking to validate structural basis of interaction with key pathways. Our findings indicate BPA may influence cellular processes, including homeostasis, stress, and cycle regulation, while activating PI3K/Akt signaling. Enrichment analysis revealed pathways associated with amoebic infection, suggesting interactions between infection status and chemical exposure. With evidence that emetine enhances cancer cell sensitivity, we hypothesize BPA may activate inflammation pathways shared with amoebic infection, particularly in predisposed individuals. Consequently, BPA might induce inflammatory microenvironment, thereby influencing progression and treatment response. This study identifies CTRC/PRDX1/SKP1 as crucial and proposes hypothesis of synergistic effects between exposure and infection history. These findings underscore incorporating environmental exposure into risk assessment, offering perspectives on carcinogenesis and avenues for prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.